Loading...
News2021-01-05T18:41:10-04:00

News

DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies

DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies November 27, 2020 08:00 ET | Source: Sorrento [...]

January 5th, 2021|Press Releases|

Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient and In Vivo Production of Antibody Therapeutics in Patients

Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient and In Vivo Production of Antibody Therapeutics in Patients September 2, 2020 [...]

September 10th, 2020|Press Releases|

Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer Therapeutics

Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer Therapeutics The combination of SmartPharm’s Gene Mab™ gene-encoded [...]

August 20th, 2020|Press Releases|

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics The combination of SmartPharm's Gene Mab™ [...]

July 24th, 2020|Press Releases|

Dr. Trevejo paper in Nature Biotechnology highlights critical considerations in the race to develop COVID-19 vaccines and antibody countermeasures

Dr. Trevejo paper in Nature Biotechnology highlights critical considerations in the race to develop COVID-19 vaccines and antibody countermeasures.In this important race to develop protections and treatments, key facets of the biology of SARS-CoV-2 are [...]

June 5th, 2020|News|
Go to Top